about
Alector Inc is a clinical-stage biotechnology company focused on developing therapies for neurodegenerative diseases. The company advances a pipeline of product candidates including Nivisnebart (AL101/GSK4527226) for Alzheimer's disease, AL137 for Al...
Read More
2.42
-0.05
(-2.02%)
221.0K
XNAS Volume
XNAS 08 Apr, 2026 3:46 PM (EDT)
Not Eligible
Expensive Valuation
Technically Moderately Bullish
Alector Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..